Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Rini, Christine	Northwestern University At Chicago United States	Mosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English- and Spanish-Speaking Stem Cell Transplant Recipients	5R01CA292116-02	Brennan Streck, Ph.D., RN, M.P.H.
Robbins, Hilary A.	International Agency For Res On Cancer United States	The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening	4R01CA262164-04	Claire Zhu, Ph.D.
Robertson, Gavin P.	Pennsylvania State Univ Hershey Med Ctr United States	Targeting Aldehyde Dehydrogenase for Cancer Prevention	5R01CA241148-05
Robertson, Sarah E	Dartmouth College United States	Learning about the effectiveness of lung cancer screening in real-world target populations	4R00CA287059-03	Neeraj Saxena, Ph.D.
Rogers, Laura Q	University Of Alabama At Birmingham United States	Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors	5R01CA235598-06	Gabriela Riscuta, M.D., CNS
Rosenberg, Daniel William	University Of Connecticut Sch Of Med/Dnt United States	Microbiota, Metabolites, and Colon Neoplasia	5R01CA252045-05	Amit Kumar, Ph.D.
Rosenbluth, Jennifer M.	University Of California, San Francisco United States	In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer	4R01CA281361-04	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-04	Rachel Altshuler, Ph.D.
Rosser, Charles J	Cedars-Sinai Medical Center United States	A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology	5R01CA277810-03	Guillermo Marquez, Ph.D.
Rotemberg, Veronica Miriam	Sloan-Kettering Inst Can Research United States	M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection	5U24CA264369-04	Guillermo Marquez, Ph.D.
Roth, Michael E.	Public Health Institute United States	Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant	3UG1CA189955-11S3	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rowland, Kendrith Martin	Carle Foundation United States	Carle Cancer Center NCI Community Oncology Research Program (NCORP)	3UG1CA189861-11S1	Vanessa A. White, M.P.H.
Russell, John A	University Of Wisconsin-Madison United States	Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment	5R37CA225608-07	Cecilia Lee, Dr.P.H., RN
Saenger, Yvonne Margaret	Albert Einstein College Of Medicine United States	Applying pathomics to establish a biosignature for aggressive skin melanoma	5R01CA260375-05	Guillermo Marquez, Ph.D.
Salami, Simpa Samuel	University Of Michigan At Ann Arbor United States	Defining the Biological Arc of Grade Group 1 Prostate Cancer	5R37CA283857-03	Guillermo Marquez, Ph.D.